SEC Form 4 · accession 0001658613-17-000001
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Edward McKechnie
Director
Period of report
Sep 16, 2015
Accepted (ET)
May 26, 2017 · 3:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Feb 22, 2017 | A | 29,091 | $0.55 | A | 253,377 | D | |
| Common Shares | holding | — | — | — | 224,286 | D |
Table II — derivative securities
No Table II lines on this filing.